ATLANTA (Reuters) - The Novartis diabetes drug Starlix failed to reduce progression to the disease or cut down on serious heart problems in patients at high risk for both diabetes and heart disease, according to a large study released on Sunday.
The 9,306-patient study tested Starlix, known chemically as nateglinide ...More
ATLANTA (Reuters) - Adding a triglyceride lowering drug to cholesterol fighting statins provided no additional protection from heart attack, stroke and death from heart disease in patients with Type 2 diabetes, according to data from a large study.
The National Institutes of Health-run study dubbed Accord aimed to see if the ...More
ATLANTA (Reuters) - An experimental, minimally invasive technique to repair the most common type of heart valve problem proved to be far safer and nearly as effective as open heart surgery, meeting the primary goals of a pivotal study, researchers said on Sunday.
Abbott Laboratories is hoping to use the data ...More
NEW YORK (Reuters Health) - People in Portland are more likely than those in Iceland to be sensitive to certain foods, but reactions to fish, eggs and cow's milk appear rare in both places, new research suggests.
The study, of more than 4,500 adults from 13 Western countries, found ...More
NEW YORK (Reuters Health) - Most youngsters grow out of having otherwise unexplained bone and muscle aches known as growing pains, researchers from Israel report.
Of 35 children who originally had growing pains, Dr. Yosef Uziel, at Meir Medical Center in Kfar-Saba, and co-investigators found that 18 -- or 51 percent -- no ...More
WASHINGTON (Reuters) - The blockbuster anti-clotting drug Plavix will carry a new warning about patients who have a poor response to the drug because they do not break it down well, U.S. regulators said on Friday.
The Food and Drug Administration said it was adding a new boxed warning to ...More
WASHINGTON (Reuters) - Vaccines that contain a mercury-based preservative called thimerosal cannot cause autism on their own, a special U.S. court ruled on Friday, dealing one more blow to parents seeking to blame vaccines for their children's illness.
The special U.S. Court of Federal Claims ruled that vaccines ...More
WASHINGTON (Reuters) - The House of Representatives Budget Committee on Monday will consider a reconciliation bill that Democrats hope clears the way for final congressional approval of an overhaul of U.S. healthcare, House Democratic Leader Steny Hoyer said on Friday.
Representative Jim Clyburn, a member of the House Democratic leadership ...More
LONDON (Reuters) - One of the world's largest studies of the contraceptive pill has found that women who have taken it can expect longer lives and are less likely to die from any cause, including cancer and heart disease.
British researchers said their study, which should reassure many millions of ...More
LONDON (Reuters) - Several drug firms have agreed on a landmark deal to supply up to 200 million doses a year of cut-price pneumococcal vaccines to developing nations, according to the global immunization alliance that is overseeing the deal.
Leading manufacturers of such vaccines include GlaxoSmithKline and Pfizer.
The agreement is ...More
